vs
阿普塔集团（ATR）与DOCUSIGN, INC.（DOCU）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是DOCUSIGN, INC.的1.2倍（$962.7M vs $818.4M），DOCUSIGN, INC.净利率更高（10.2% vs 7.7%，领先2.5%），阿普塔集团同比增速更快（13.5% vs 8.4%），DOCUSIGN, INC.自由现金流更多（$262.9M vs $96.9M）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
DocuSign是总部位于美国加利福尼亚州旧金山的软件企业，为各类机构提供多设备支持的电子协议管理及电子签名相关产品。截至2025年，公司在180个国家拥有约170万客户，其处理的签名符合美国ESIGN法案、欧盟eIDAS法规要求，满足欧盟高级及合格签名标准。
ATR vs DOCU — 直观对比
营收规模更大
ATR
是对方的1.2倍
$818.4M
营收增速更快
ATR
高出5.1%
8.4%
净利率更高
DOCU
高出2.5%
7.7%
自由现金流更多
DOCU
多$166.0M
$96.9M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $818.4M |
| 净利润 | $74.3M | $83.7M |
| 毛利率 | — | 79.2% |
| 营业利润率 | 11.0% | 10.4% |
| 净利率 | 7.7% | 10.2% |
| 营收同比 | 13.5% | 8.4% |
| 净利润同比 | -26.4% | 34.1% |
| 每股收益（稀释后） | $1.13 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRDOCU
| Q4 25 | $962.7M | $818.4M | ||
| Q3 25 | $961.1M | $800.6M | ||
| Q2 25 | $966.0M | $763.7M | ||
| Q1 25 | $887.3M | — | ||
| Q4 24 | $848.1M | — | ||
| Q3 24 | $909.3M | — | ||
| Q2 24 | $910.1M | — | ||
| Q1 24 | $915.4M | — |
净利润ATRDOCU
| Q4 25 | $74.3M | $83.7M | ||
| Q3 25 | $127.9M | $63.0M | ||
| Q2 25 | $111.7M | $72.1M | ||
| Q1 25 | $78.8M | — | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $100.0M | — | ||
| Q2 24 | $90.5M | — | ||
| Q1 24 | $83.1M | — |
毛利率ATRDOCU
| Q4 25 | — | 79.2% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 79.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ATRDOCU
| Q4 25 | 11.0% | 10.4% | ||
| Q3 25 | 14.2% | 8.1% | ||
| Q2 25 | 14.9% | 7.9% | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 12.2% | — |
净利率ATRDOCU
| Q4 25 | 7.7% | 10.2% | ||
| Q3 25 | 13.3% | 7.9% | ||
| Q2 25 | 11.6% | 9.4% | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 9.1% | — |
每股收益（稀释后）ATRDOCU
| Q4 25 | $1.13 | $0.40 | ||
| Q3 25 | $1.92 | $0.30 | ||
| Q2 25 | $1.67 | $0.34 | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — | ||
| Q1 24 | $1.23 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $583.3M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $2.0B |
| 总资产 | $5.3B | $4.0B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRDOCU
| Q4 25 | $409.5M | $583.3M | ||
| Q3 25 | $264.8M | $600.0M | ||
| Q2 25 | $169.8M | $657.4M | ||
| Q1 25 | $136.8M | — | ||
| Q4 24 | $226.2M | — | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — | ||
| Q1 24 | $201.1M | — |
总债务ATRDOCU
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRDOCU
| Q4 25 | $2.7B | $2.0B | ||
| Q3 25 | $2.8B | $2.0B | ||
| Q2 25 | $2.7B | $2.0B | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.3B | — |
总资产ATRDOCU
| Q4 25 | $5.3B | $4.0B | ||
| Q3 25 | $5.1B | $3.9B | ||
| Q2 25 | $4.9B | $3.9B | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.4B | — |
负债/权益比ATRDOCU
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $290.3M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $262.9M |
| 自由现金流率自由现金流/营收 | 10.1% | 32.1% |
| 资本支出强度资本支出/营收 | 9.0% | 3.3% |
| 现金转化率经营现金流/净利润 | 2.47× | 3.47× |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRDOCU
| Q4 25 | $183.7M | $290.3M | ||
| Q3 25 | $177.6M | $246.1M | ||
| Q2 25 | $126.0M | $251.4M | ||
| Q1 25 | $82.7M | — | ||
| Q4 24 | $178.2M | — | ||
| Q3 24 | $229.3M | — | ||
| Q2 24 | $143.6M | — | ||
| Q1 24 | $92.3M | — |
自由现金流ATRDOCU
| Q4 25 | $96.9M | $262.9M | ||
| Q3 25 | $114.3M | $217.6M | ||
| Q2 25 | $62.5M | $227.8M | ||
| Q1 25 | $25.9M | — | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | — | ||
| Q2 24 | $75.4M | — | ||
| Q1 24 | $16.7M | — |
自由现金流率ATRDOCU
| Q4 25 | 10.1% | 32.1% | ||
| Q3 25 | 11.9% | 27.2% | ||
| Q2 25 | 6.5% | 29.8% | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 1.8% | — |
资本支出强度ATRDOCU
| Q4 25 | 9.0% | 3.3% | ||
| Q3 25 | 6.6% | 3.6% | ||
| Q2 25 | 6.6% | 3.1% | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 8.3% | — |
现金转化率ATRDOCU
| Q4 25 | 2.47× | 3.47× | ||
| Q3 25 | 1.39× | 3.91× | ||
| Q2 25 | 1.13× | 3.49× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
DOCU
| Subscription And Circulation | $801.0M | 98% |
| Professional Services And Other | $17.4M | 2% |
